Our Firm is representing numerous Lipitor lawsuit plaintiffs in this litigation who put forth similar allegations regarding the use of the statin medication and diabetes.
New York, NY (PRWEB) February 27, 2015
The federal court overseeing more than 1,800 Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege use of the statin medication can increase a person’s risk for developing Type 2 diabetes has issued a new order pertaining to discovery in the cases selected for the proceeding’s first two bellwether trials, Bernstein Liebhard LLP comments. The Order, which was issued in the U.S. District Court, District of South Carolina, on February 25th, directs the parties to schedule certain witness depositions before May 15, 2015. Among other things, the Order also notes that collection of certain records pertaining to the bellwether plaintiffs will continue through September 21, 2015, or four weeks before trial, whichever is later. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)
“Our Firm is representing numerous Lipitor lawsuit plaintiffs in this litigation who put forth similar allegations regarding the use of the statin medication and diabetes. As the outcomes of bellwether trials are intended to provide insight into jury rulings in cases involving similar allegations, we are pleased to see that case-specific discovery has commenced in the federal Lipitor litigation. We look forward to the start of these trials,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.
Lipitor Diabetes Litigation
Court documents indicate that all of the Lipitor lawsuits pending in the District of South Carolina similarly allege that the Pfizer, Inc. failed to warn patients that use of the cholesterol-lowering statin can cause Type 2 diabetes. In an Order dated January 30th, the Court designated four lawsuits as bellwether trial candidates, and indicated that the first trial would involve a case filed on behalf of a woman who alleges that she was in good health before she began taking Lipitor, and later developed diabetes due to its use. An Order issued on February 4th directed that the case would go to trial on October 19, 2014
According to court documents, the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. However, plaintiffs in Lipitor lawsuits claim that new information added to the drug’s label following the FDA’s announcement fails to adequately warn patients about the drug’s association with diabetes.
Lipitor patients who allegedly developed Type 2 diabetes due to the medication may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury related damages. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com